Pre-travel Health Advice for Patients With Cardiovascular Disease

Document Type : Review Article

Authors

1 School of Medicine, National University of Ireland Galway, Galway, Ireland

2 School of Medicine, Trinity College Dublin, Dublin, Ireland

3 National Institute for Prevention and Cardiovascular Health, Galway, Ireland

4 School of Medicine, International Medical University, Kuala Lumpur, Malaysia

10.15171/ijtmgh.2019.18

Abstract

Cardiovascular disease (CVD) is the leading cause of death among international travellers. Practitioner knowledge of the effects of CVD on international travel is imperative in order to promote a healthy travel experience. This review aimed to explore the available literature on this topic. The PubMed database was accessed to source relevant literature using combinations of relevant keywords as search terms. Articles were restricted to those published in the English language through March 2019. Of 1726 article records retrieved, 73 relevant papers were examined carefully. The results of this narrative review are related to multiple aspects of CVD and travel. The pre-travel consultation should address issues regarding vaccinations, travel insurance, anticoagulation, and medical devices. Additional vaccines to be discussed include influenza, pneumococcal, and hepatitis B. Patients with CVD should be advised of the need to carry a copy of their ECG, prescription(s), and pacemaker manufacturer’s card. Knowledge of the location overseas of automated external defibrillators and awareness of health risks associated with strenuous adventure activities are important for CVD travellers. Medical tourism for patients with CVD is briefly considered. Space tourism is an emerging category of extreme international travel that requires specialized pre-travel preparation. This narrative review article highlights the gaps in the travel medicine literature in relation to CVD. A strong evidence base for most recommendations is lacking. Future scholarly efforts are warranted to facilitate more robust travel recommendations for CVD patients. No qualitative studies to date have described the experiences of international travellers with CVD.

Keywords

References

  1. World Tourism Organization. UNWTO Annual Report, 2017. http://publications.unwto.org/publication/unwto-annual-report-2017. Accessed March 1, 2019.
  2. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-2381. doi:10.1093/eurheartj/ehw106.
  3. Wieten RW, van der Schalie M, Visser BJ, Grobusch MP, van Vugt M. Risk factors and pre-travel healthcare of international travellers attending a Dutch travel clinic: a cross-sectional analysis. Travel Med Infect Dis. 2014;12(5):511-524. doi:10.1016/j.tmaid.2014.05.004.
  4. Valani R, Cornacchia M, Kube D. Flight diversions due to onboard medical emergencies on an international commercial airline. Aviat Space Environ Med. 2010;81(11):1037-1040. doi:10.3357/ASEM.2789.2010.
  5. Chandra A, Conry S. In-flight medical emergencies. West J Emerg Med. 2013;14(5):499-504. doi:10.5811/westjem.2013.4.16052.
  6. Oliveira-Silva I, Leicht AS, Moraes MR, et al. Heart rate and cardiovascular responses to commercial flights: relationships with physical fitness. Front Physiol. 2016;7:648. doi:10.3389/fphys.2016.00648.
  7. Flaherty GT, Geoghegan R, Brown IG, Finucane FM. Severe obesity as a barrier to international travel: a qualitative analysis. J Travel Med. 2019;26(3). doi:10.1093/jtm/taz018.
  8. Ingle L, Hobkirk J, Damy T, Nabb S, Clark AL, Cleland JG. Experiences of air travel in patients with chronic heart failure. Int J Cardiol. 2012;158(1):66-70. doi:10.1016/j.ijcard.2010.12.101.
  9. Hobkirk JP, Damy T, Walters M, et al. Effects of reducing inspired oxygen concentration for one hour in patients with chronic heart failure: implications for air travel. Eur J Heart Fail. 2013;15(5):505- 510. doi:10.1093/eurjhf/hft003.
  10. Hammadah M, Kindya BR, Allard-Ratick MP, et al. Navigating air travel and cardiovascular concerns: Is the sky the limit? Clin Cardiol. 2017;40(9):660-666. doi:10.1002/clc.22741.
  11. Silverman D, Gendreau M. Medical issues associated with commercial flights. Lancet. 2009;373(9680):2067-2077. doi:10.1016/S0140-6736(09)60209-9.
  12. Smith D, Toff W, Joy M, et al. Fitness to fly for passengers with cardiovascular disease. Heart. 2010;96 Suppl 2:ii1-16. doi:10.1136/hrt.2010.203091.
  13. Barros A, Duchateau FX, Huff JS, Verner L, O’Connor RE, Brady WJ. Nonurgent commercial air travel after nonhemorrhagic cerebrovascular accident. Air Med J. 2014;33(3):106-108. doi:10.1016/j.amj.2014.02.003.
  14. International Air Transport Association (IATA). Medical Manual, 2018. https://www.iata.org/publications/Pages/medical-manual.aspx. Accessed March 1, 2019.
  15. Alonso-Cánovas A, de Felipe-Mimbrera A, González-Valcárcel J, García-Barragán N, Corral I, Masjuan J. Neurology at the airport. J Neurol Neurosurg Psychiatry. 2011;82(9):981-985. doi:10.1136/jnnp.2011.243709.
  16. Humaidan H, Yassi N, Weir L, Davis SM, Meretoja A. Airplane stroke syndrome. J Clin Neurosci. 2016;29:77-80. doi:10.1016/j.jocn.2015.12.015.
  17. Álvarez-Velasco R, Masjuan J, DeFelipe A, et al. Stroke in commercial flights. Stroke. 2016;47(4):1117-1119. doi:10.1161/STROKEAHA.115.012637.
  18. Sand M, Bollenbach M, Sand D, et al. Epidemiology of aeromedical evacuation: an analysis of 504 cases. J Travel Med. 2010;17(6):405-409. doi:10.1111/j.1708-8305.2010.00454.x.
  19. Hasler RM, Albrecht S, Exadaktylos AK, Albrecht R. Repatriations and 28-day mortality of ill and injured travellers: 12 years of experience in a Swiss emergency department. Swiss Med Wkly. 2015;145:w14208. doi:10.4414/smw.2015.14208.
  20. Harinck E, Hutter PA, Hoorntje TM, et al. Air travel and adults with cyanotic congenital heart disease. Circulation. 1996;93(2):272- 276. doi:10.1161/01.CIR.93.2.272.
  21. Spoorenberg ME, van den Oord MH, Meeuwsen T, Takken T. Fitness to fly testing in patients with congenital heart and lung disease. Aerosp Med Hum Perform. 2016;87(1):54-60. doi:10.3357/AMHP.4408.2016.
  22. Windsor JS, Firth PG, Grocott MP, Rodway GW, Montgomery HE. Mountain mortality: a review of deaths that occur during recreational activities in the mountains. Postgrad Med J. 2009;85(1004):316-321. doi:10.1136/pgmj.2009.078824.
  23. Bärtsch P, Swenson ER. Acute high-altitude illnesses. N Engl J Med. 2013;368(24):2294-2302. doi:10.1056/NEJMcp1214870.
  24. Smith TG, Talbot NP, Chang RW, et al. Pulmonary artery pressure increases during commercial air travel in healthy passengers. Aviat Space Environ Med. 2012;83(7):673-676. doi:10.3357/ASEM.3235.2012.
  25. Grimminger J, Richter M, Tello K, Sommer N, Gall H, Ghofrani HA. Thin air resulting in high pressure: mountain sickness and hypoxia-induced pulmonary hypertension. Can Respir J. 2017;2017:8381653. doi:10.1155/2017/8381653.
  26. Flaherty GT, Kennedy KM. Preparing patients for travel to high altitude: advice on travel health and chemoprophylaxis. Br J Gen Pract. 2016;66(642):e62-64. doi:10.3399/bjgp16X683377.
  27. Flaherty G, De Freitas S. A Heart for Travel: Travel Health Considerations for Patients with Heart Disease and Cardiac Devices. Ir Med J. 2016;109(10):486.
  28. Donegani E, Hillebrandt D, Windsor J, et al. Pre-existing cardiovascular conditions and high altitude travel. Consensus statement of the Medical Commission of the Union Internationale des Associations d’Alpinisme (UIAA MedCom) Travel Medicine and Infectious Disease. Travel Med Infect Dis. 2014;12(3):237- 252. doi:10.1016/j.tmaid.2014.02.004.
  29. Burtscher M, Philadelphy M, Gatterer H, Burtscher J, Likar R. Submaximal exercise testing at low altitude for prediction of exercise tolerance at high altitude. J Travel Med. 2018;25(1). doi:10.1093/jtm/tay011.
  30. Klug G, Schenk S, Dorler J, et al. Occurrence of acute myocardial infarction in winter tourists: data from a retrospective questionnaire. Clin Res Cardiol. 2011;100(8):669-674. doi:10.1007/s00392-011-0294-3.
  31. Nathanson AT, Young JM, Young C. Pre-participation medical evaluation for adventure and wilderness watersports. Clin J Sport Med. 2015;25(5):425-431. doi:10.1097/JSM.0000000000000252.
  32. Lippmann J, Mc DTD, Stevenson C, Williams J, Mitchell SJ. Diving with pre-existing medical conditions. Diving Hyperb Med. 2017;47(3):180-190. doi:10.28920/dhm47.3.180-190.
  33. Åsmul K, Irgens Å, Grønning M, Møllerløkken A. Diving and long-term cardiovascular health. Occup Med (Lond). 2017;67(5):371- 376. doi:10.1093/occmed/kqx049.
  34. Shattock MJ, Tipton MJ. ‘Autonomic conflict’: a different way to die during cold water immersion? J Physiol. 2012;590(14):3219-3230. doi:10.1113/jphysiol.2012.229864.
  35. Kenny GP, Yardley J, Brown C, Sigal RJ, Jay O. Heat stress in older individuals and patients with common chronic diseases. Cmaj. 2010;182(10):1053-1060. doi:10.1503/cmaj.081050.
  36. Cui J, Sinoway LI. Cardiovascular responses to heat stress in chronic heart failure. Curr Heart Fail Rep. 2014;11(2):139-145. doi:10.1007/s11897-014-0191-y.
  37. Baaghideh M, Mayvaneh F. Climate change and simulation of cardiovascular disease mortality: A case study of Mashhad, Iran. Iran J Public Health. 2017;46(3):396-407.
  38. Sanderson M, Arbuthnott K, Kovats S, Hajat S, Falloon P. The use of climate information to estimate future mortality from high ambient temperature: A systematic literature review. PLoS One. 2017;12(7):e0180369. doi:10.1371/journal.pone.0180369.
  39. Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015(5):Cd005050. doi:10.1002/14651858.CD005050.pub3.
  40. Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264-274. doi:10.1001/jama.2014.18229.
  41. Ren S, Newby D, Li SC, et al. Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis. Open Heart. 2015;2(1):e000247. doi:10.1136/openhrt-2015-000247.
  42. Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Hepatitis B virus infection and risk of coronary artery disease: a meta-analysis. Ann Transl Med. 2016;4(21):423. doi:10.21037/atm.2016.11.12.
  43. Ciszewski A. Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases. Vaccine. 2018;36(2):202-206. doi:10.1016/j.vaccine.2017.11.078.
  44. Leggat PA, Griffiths R, Leggat FW. Emergency assistance provided abroad to insured travellers from Australia. Travel Med Infect Dis. 2005;3(1):9-17. doi:10.1016/j.tmaid.2004.07.002.
  45. Crossland DS, Jackson SP, Lyall R, et al. Life insurance and mortgage application in adults with congenital heart disease. Eur J Cardiothorac Surg. 2004;25(6):931-934. doi:10.1016/j.ejcts.2004.01.040.
  46. Ladouceur M, Iserin L, Cohen S, Legendre A, Boudjemline Y, Bonnet D. Key issues of daily life in adults with congenital heart disease. Arch Cardiovasc Dis. 2013;106(6-7):404-412. doi:10.1016/j.acvd.2013.02.004.
  47. Pickup L, Bowater S, Thorne S, Clift P, Hudsmith L. Travel insurance in adult congenital heart disease - Do they declare their condition? Int J Cardiol. 2016;223:316-317. doi:10.1016/j.ijcard.2016.08.098.
  48. Teichman PG, Donchin Y, Kot RJ. International aeromedical evacuation. N Engl J Med. 2007;356(3):262-270. doi:10.1056/NEJMra063651.
  49. Lee YH, Lu CW, Wu PZ, Huang HL, Wu YC, Huang KC. Attitudes and awareness of medical assistance while traveling abroad. Global Health. 2018;14(1):67. doi:10.1186/s12992-018-0382-5.
  50. Alleman BW, Luger T, Reisinger HS, Martin R, Horowitz MD, Cram P. Medical tourism services available to residents of the United States. J Gen Intern Med. 2011;26(5):492-497. doi:10.1007/s11606-010-1582-8.
  51. Patients Beyond Borders. Medical Tourism Statistics and Facts, 2019. Available at: https://patientsbeyondborders.com/medical-tourism-statistics-facts. Accessed February 28, 2019.
  52. Jacobs JP, Horowitz MD, Mavroudis C, Siegel A, Sade RM. Surgical tourism: the role of cardiothoracic surgery societies in evaluating international surgery centers. Ann Thorac Surg. 2013;96(1):8-14. doi:10.1016/j.athoracsur.2013.02.058.
  53. Horowitz MD, Rosensweig JA, Jones CA. Medical tourism: globalization of the healthcare marketplace. MedGenMed. 2007;9(4):33.
  54. Sade RM, Kavarana MN. Surgical ethics: today and tomorrow. Future Cardiol. 2017;13(6):567-578. doi:10.2217/fca-2017-0057.
  55. Nunnally B, Josseaume J, Duchateau FX, O’Connor RE, Verner L, Brady WJ. Anticoagulation and Non-urgent Commercial Air Travel: A Review of the Literature. Air Med J. 2015;34(5):269-277. doi:10.1016/j.amj.2015.06.006.
  56. Ringwald J, Grauer M, Eckstein R, Jelinek T. The place of new oral anticoagulants in travel medicine. Travel Med Infect Dis. 2014;12(1):7-19. doi:10.1016/j.tmaid.2013.11.005.
  57. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962. doi:10.1016/S0140-6736(13)62343-0.
  58. Casajuana J, Iglesias B, Fàbregas M, et al. Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial. BMC Blood Disord. 2008;8:1. doi:10.1186/1471-2326-8-1.
  59. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart. 2001;86(3):246-248. doi:10.1136/heart.86.3.246.
  60. Kolb C, Schmieder S, Lehmann G, et al. Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol. 2003;41(11):2054-2059. doi:10.1016/S0735-1097(03)00424-8.
  61. Jilek C, Tzeis S, Vrazic H, et al. Safety of screening procedures with hand-held metal detectors among patients with implanted cardiac rhythm devices: a cross-sectional analysis. Ann Intern Med. 2011;155(9):587-592. doi:10.7326/0003-4819-155-9-201111010-00005.
  62. Aagaard R, Grove EL, Mikkelsen R, Wolff A, Iversen KW, Løfgren B. Limited public ability to recognise and understand the universal sign for automated external defibrillators. Heart. 2016;102(10):770-774. doi:10.1136/heartjnl-2015-308700.
  63. Leung AC, Asch DA, Lozada KN, et al. Where are lifesaving automated external defibrillators located and how hard is it to find them in a large urban city? Resuscitation. 2013;84(7):910-914. doi:10.1016/j.resuscitation.2013.01.010.
  64. Ho CL, Lui CT, Tsui KL, Kam CW. Investigation of availability and accessibility of community automated external defibrillators in a territory in Hong Kong. Hong Kong Med J. 2014;20(5):371-378. doi:10.12809/hkmj144258.
  65. Griffis HM, Band RA, Ruther M, et al. Employment and residential characteristics in relation to automated external defibrillator locations. Am Heart J. 2016;172:185-191. doi:10.1016/j.ahj.2015.09.022.
  66. Sakai T, Iwami T, Kitamura T, et al. Effectiveness of the new ‘Mobile AED Map’ to find and retrieve an AED: A randomised controlled trial. Resuscitation. 2011;82(1):69-73. doi:10.1016/j.resuscitation.2010.09.466.
  67. Pulver A, Wei R, Mann C. Locating AED enabled medical drones to enhance cardiac arrest response times. Prehosp Emerg Care. 2016;20(3):378-389. doi:10.3109/10903127.2015.1115932.
  68. Cater CI. Steps to Space; opportunities for astrotourism. Tour Manag. 2010;31(6):838-845. doi:10.1016/j.tourman.2009.09.001.
  69. Space Tourism Society. 2019. http://spacetourismsociety.org/. Accessed March 27, 2019.
  70. Tanaka K, Nishimura N, Kawai Y. Adaptation to microgravity, deconditioning, and countermeasures. J Physiol Sci. 2017;67(2):271- 281. doi:10.1007/s12576-016-0514-8.
  71. Flaherty GT, Kenny-Gibson W, Lang MJ. The Final Frontier-What Should the Travel Medicine Practitioner Know About Space Flight Participation? J Travel Med. 2015;22(6):425-427. doi:10.1111/jtm.12242.
  72. Evans JM, Knapp CF, Goswami N. Artificial gravity as a countermeasure to the cardiovascular deconditioning of spaceflight: gender perspectives. Front Physiol. 2018;9:716. doi:10.3389/fphys.2018.00716.
  73. Braunecker S, Douglas B, Hinkelbein J. Comparison of different techniques for in microgravity-a simple mathematic estimation of cardiopulmonary resuscitation quality for space environment. Am J Emerg Med. 2015;33(7):920-924. doi:10.1016/j.ajem.2015.04.018.
International Journal of Travel Medicine and Global Health
Volume 7, Issue 3 - Serial Number 26
September 2019
Pages 79-85

Files

History

  • Receive Date: 08 April 2019
  • Revise Date: 18 June 2019
  • Accept Date: 08 July 2019

Share

How to cite

Statistics